These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3. Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222 [TBL] [Abstract][Full Text] [Related]
12. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection. Jrad-Battikh N; Souii A; Oueslati L; Aouni M; Hober D; Gharbi J; Ben M'hadheb-Gharbi M Curr Microbiol; 2014 Apr; 68(4):503-9. PubMed ID: 24322405 [TBL] [Abstract][Full Text] [Related]
13. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination. Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Park JH; Kim DS; Cho YJ; Kim YJ; Jeong SY; Lee SM; Cho SJ; Yun CW; Jo I; Nam JH Vaccine; 2009 Mar; 27(13):1974-83. PubMed ID: 19168108 [TBL] [Abstract][Full Text] [Related]
15. Modulation of murine coxsackievirus-induced myocarditis utilizing anti-idiotypes. Paque RE; Miller R Viral Immunol; 1987-1988; 1(3):207-24. PubMed ID: 3509677 [TBL] [Abstract][Full Text] [Related]
17. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis. Fan X; Yue Y; Xiong S Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Paque RE; Gauntt CJ; Nealon TJ Infect Immun; 1981 Jan; 31(1):470-9. PubMed ID: 6260666 [TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice. Leipner C; Borchers M; Merkle I; Stelzner A J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212 [TBL] [Abstract][Full Text] [Related]
20. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Fohlman J; Pauksen K; Morein B; Bjare U; Ilbäck NG; Friman G Scand J Infect Dis Suppl; 1993; 88():103-8. PubMed ID: 8390713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]